Lineage Cell Therapeutics, Inc.LCTXNYSE
LOADING
|||
Current ratio (current assets / current liabilities)
| Period | Value | Change |
|---|---|---|
| 2024 | 3.65 | +70.5% |
| 2023 | 2.14 | -32.3% |
| 2022 | 3.16 | +33.5% |
| 2021 | 2.37 | -58.2% |
| 2020 | 5.66 | -36.1% |
| 2019 | 8.86 | +65.9% |
| 2018 | 5.34 | -13.9% |
| 2017 | 6.20 | +113.8% |
| 2016 | 2.90 | -23.5% |
| 2015 | 3.79 | - |